July 30, 2018
Beximco’s fifth ANDA approved in USA
Beximco Pharmaceuticals got approval from the US Food and Drug Administration (FDA), for its Nadolol tablets, a generic equivalent of Bristol-Myers Squibb’s…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Beximco
January 30, 2018
Beximco increases profit in Q2 2017
The London-listed Bangladesh-based pharmaceutical company, Beximco, has had net sales in the second quarter increased 12.8% to BDT 4,359.9m /…
November 14, 2017
Beximco increases comprehensive net income in Q1 2017, ships second product to US
Beximco Pharmaceuticals last week started the export of Sotalol Hydrochloride, a generic version of the cardiovascular drug Betapace, to the US.
January 27, 2017
Beximco 16% sales rise drives profit up for the half year
Beximco Pharmaceuticals has posted earnings of $1,113,722, for the second half of 2016, compared to $944,662 to the same period last year.
January 25, 2017
Beximco Pharma in JV with Malaysia-based BioCare Manufacturing
Beximco Pharmaceuticals has went overseas to form a joint venture (JV) with a Malaysia-based BioCare Manufacturing. This is the Bangladesh’s company’s first such JV.
December 19, 2016
Bangladesh-based drugmaker gets FDA’s approval for its generic Bristol-Myers’s diabetes tablets
Bangladesh-based drugmaker Beximco has received approval for its Bristol-Myers Squibb’s (BMS) generic equivalent Glucophage XR tablets, Metformin from the US…
October 25, 2016
Bangladesh’s Beximco gets its second US FDA product approval
Bangladesh-based Beximco, the largest country’s pharmaceutcals exporter, has received its second US FDA …
October 19, 2016
Beximco Pharmaceutical to declare cash and stock dividends at next AGM
A Bangladesh based, AIM listed Beximco Pharmaceuticals has announced that it would declare/approve 5% final Cash Dividend, 5% Stock Dividend and 10% Cash Dividend